Roshawn Blunt has more than 25 years of experience in the biopharmaceutical and medical device industries. She founded and currently serves as managing director of 1798, LLC., a national health care consulting firm focused on educating and developing strategies for clients to address health care compliance, reimbursement, health policy and patient access issues. Ms. Blunt began her pharmaceutical career at The Boston Consulting Group, working primarily in the health care industry. Prior to that, she held a variety of strategic reimbursement and commercialization positions at Amgen, Inc. Ms. Blunt was also the first global director of health economics and reimbursement for Biosense Webster, Inc., a Johnson & Johnson company. Prior to starting 1798 Consultants, Ms. Blunt was vice president of strategy, planning, and communication at Long Beach Memorial Center and Miller Children’s Hospital.
Ms. Blunt graduated from Princeton University, where she earned her A.B. from the Princeton School of Public and International Affairs . She earned her MBA from Kellogg School of Management at Northwestern University.